Stocks · Health care · Services-Offices & Clinics of Doctors of Medicine

Starling Oncology, Inc.

STLN Clue Score47
United States Fiscal year ends December CIK 0001799191 Results filed 5 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Robert Ross Carter
2 Jan 2026
Chief Financial Officer
Sell
247
$3.56
$879.32
Brad Hively
15 Dec 2025
Director
Sell
13,333
$3.77
$50.29K
Mark L Pacala
18 Nov 2025
Director
Sell
46,630
$4.00
$186.52K
Mark L Pacala
18 Nov 2025
Director
Sell
1,210
$4.00
$4.84K
Mark L Pacala
18 Nov 2025
Director
Sell
2,160
$4.00
$8.64K

What was left out

Form 4 filings counted 56
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 2
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 5,316,873
History held since 17 Mar 2020